Anti-CD38 autoimmunity in children with newly diagnosed type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 12, 2005, Pages 1417-1423

  Pupilli, C ^a   Antonelli, A ^b   Iughetti, L ^c   D'Annunzio, G ^d   Cotellessa, M ^e   Vanelli, M ^f   Okamoto, H ^g   Lorini, R ^e   Ferrannini, Ele ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY OF PARMA   (Italy)

^g TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD38 antibodies; Children; GAD antibodies; Type 1 diabetes mellitus

Indexed keywords

CD38 ANTIBODY; CELL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 30944446824     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.12.1417     Document Type: Article

References (27)

1. Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 1996; 10: 1408-1417.
2. Antonelli A, Ferrannini E. CD38 autoimmunity: recent advances and relevance to human diabetes. J Endocrinol Invest 2004; 27: 695-707.
3. Lee HC. Mechanisms of calcium signaling by cyclic ADP-ribose and NAADP. Physiol Rev 1997; 77: 1133-1164.
4. Guse AH. Cyclic ADP-ribose. J Mol Med 2000; 78: 26-35.
5. Mizuguchi M, Otsuka N, Sato M, Ishii Y, Kon S, Yamada M, Nishina H, Katada T, Ikeda K. Neuronal localization of CD38 antigen in the human brain. Brain Res 1995; 697: 235-240.
6. Fernandez JE, Deaglio S, Donati D, Beusan IS, Corno F, Forni M, Falini B, Malavasi F. Analysis of the distribution of human CD38 and its ligand CD31 in normal tissues. J Biol Regul Homeost Agents 1998; 12: 81-91.
7. Khoo KM, Chang CF. Characterization and localization of CD38 in the vertebrate eye. Brain Res 1999; 821: 17-25.
8. Sun L, Adebanjo OA, Moonga BS, Corisdeo S, Anandatheerthavarada HK, Biswas G, Arakawa T, Hakeda Y, Koval A, Sodam B, Bevis PJ, Moser AJ, Lai FA, Epstein S, Troen BR, Kumegawa M, Zaidi M. CD38/ADP-ribosyl cyclase: a new role in the regulation of osteoclastic bone resorption. J Cell Biol 1999; 146: 1161-1172.
9. Okamoto H, Takasawa S, Nata K, Kato I, Tohgo A, Noguchi N. Physiological and pathological significance of the CD38-cyclic ADP-ribose signaling system. Chem Immunol 2000; 75: 121-145.
10. Takasawa S, Tohgo A, Noguchi N, Koguma T, Nata K, Sugimoto T, Yonekura H, Okamoto H. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem 1993; 268: 26052-26054.
11. Pupilli C, Giannini S, Marchetti P, Lupi R, Antonelli A, Malavasi F, Takasawa S, Okamoto H, Ferrannini E. Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes 1999; 48: 2309-2315.
12. Okamoto H, Takasawa S, Nata K. The CD38-cyclic ADP-ribose signaling system in insulin secretion: molecular basis and clinical implications. Diabetologia 1997; 40: 1485-1491.
13. Yagui K, Shimada F, Mimura M, Hashimoto N, Suzuki Y, Tokuyama Y, Nata K, Tohgo A, Ikehata F, Takasawa S, Okamoto H, Makino H, Saito Y, Kanatsuka A. A missense mutation in the C ? gene, a novel factor for insulin secretion: association with type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro. Diabetologia 1998; 41: 1024-1028.
14. Antonelli A, Tuomi T, Nannipieri M, Fallahi P, Nesti C, Okamoto H, Groop L, Ferrannini L. Autoimmunity to CD38 and GAD in type II and type I diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 2002; 45: 1298-1306.
15. Ikehata F, Sato J, Nata K, Toligo A, Nakazawa T, Kato I, Kobayashi S, Akiyama T, Takasawa S, Toyota T, Okamoto H. Autoantibodies against D38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose induced insulin secretion in noninsulin-dependent diabetes patients. J Clin Invest 1998; C102: 395-401
16. Antonelli A, Baj G, Marchetti P, Fallahi P, Surico N, Pupilli C, Malavasi F, Ferrannini E. Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. Diabetes 2001; 50: 985-991.
17. Lorini R, Alibrandi A, Vitali L, Klersy C, Martinetti M, Betterle C, D'Annunzio G, Bonifacio E. Risk of type 1 diabetes development in children with incidental hyperglycemia: a multicenter Italian study. Diabetes Care 2001; 24: 1210-1216.
18. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360-1368.
19. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 1998; 47: 1857-1866.
20. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 1993; 9: 350-356.
21. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M, Hulinska H, Hulinsky I, Silvestrini RA, Kamath S. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994;: 37: 1113-1120.
22. Schernthaner G, Hink S, Kopp HP, Muzyka B, Streit G, Kroiss A. Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1.5 diabetes). Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2): S94-108.
23. Antonelli A., Fallahi P, Nesti C, Pupilli C, Marchetti P, Takasawa S, Hokamoto H, Ferrannini E. Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clin Exp Immunol 2001; 126: 426-431.
24. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; ii: 1279-1283.
25. Li L, Hagopian WA, Brashear HR, Daniels T, Lernmark A. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J Immunol 1994; 152: 930-934.
26. Martin S, Kardorf J, Schulte B, Lampeter EF, Gries FA, Melchers I, Wagner R, Bertrams J, Roep BO, Pfützer A, Pietropaolo M, Kolb H. Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia 1995; 38: 351-355.
27. Leslie RDG, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in type 1 (insulin dependent) diabetes. Diabetologia 1999; 42: 3-15.